Levitra, Staxyn, Vivanza (vardenafil) is a small molecule pharmaceutical. Vardenafil was first approved as Levitra on 2003-03-04. It is used to treat vasculogenic impotence in the USA. It has been approved in Europe to treat erectile dysfunction. The pharmaceutical is active against cGMP-specific 3',5'-cyclic phosphodiesterase. In addition, it is known to target cAMP-specific 3',5'-cyclic phosphodiesterase 4B. Levitra's patents are valid until 2028-12-23 (FDA).
|Trade Name||Levitra, Vivanza|
|Indication||erectile dysfunction, vasculogenic impotence|
|Drug Class||Pde5 inhibitors|